Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab

Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab

Only limited data on laboratory parameter dynamics and safety under prolonged biologic treatment in a “real-world” scenario are available for recommendations on screening and monitoring. This study is a retrospective analysis of routine parameter dynamics and laboratory adverse events (L...

Full description

Bibliographic Details
Main Authors: Jochen H. Hoffmann, Christian Knoop, Alexander H. Enk, Eva N. Hadaschik
Format: Article
Language:English
Published: Society for Publication of Acta Dermato-Venereologica 2017-03-01
Series:Acta Dermato-Venereologica
Subjects:
psoriasis
biologicalproducts
adalimumab
etanercept
ustekinumab
neutrophils
lymphocytes
transaminases
triglycerides
bloodcellcount
clinicalchemistrytests.
Online Access: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2644

Internet

https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2644

Similar Items